Financhill
Sell
17

BCHT Quote, Financials, Valuation and Earnings

Last price:
$0.53
Seasonality move :
8.88%
Day range:
$0.52 - $0.55
52-week range:
$0.52 - $1.40
Dividend yield:
0%
P/E ratio:
19.50x
P/S ratio:
3.18x
P/B ratio:
26.42x
Volume:
51.8K
Avg. volume:
85.8K
1-year change:
-44.05%
Market cap:
$50.6M
Revenue:
$17.9M
EPS (TTM):
-$0.01
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $11.4M $8.2M $13M $21.6M $17.9M
Revenue Growth (YoY) -7.15% -28.54% 59.49% 66.16% -17.02%
 
Cost of Revenues $8.3M $5.4M $7.9M $14.6M $12.2M
Gross Profit $3.1M $2.7M $5.1M $7M $5.8M
Gross Profit Margin 26.99% 33.32% 38.99% 32.48% 32.15%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $6.4M $5.9M $5.9M $6.1M $14.2M
Other Inc / (Exp) -$344.9K $59.4K $69.2K -$897K $16.2M
Operating Expenses $6.4M $5.9M $5.9M $6.1M $14.2M
Operating Income -$3.3M -$3.2M -$861K $904K -$8.4M
 
Net Interest Expenses $2.4M $2.7M $2.8M $1.6M $1.4M
EBT. Incl. Unusual Items -$6.1M -$5.8M -$3.6M -$1.6M $6.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $14K $10K $23K $18K $473.2K
Net Income to Company -$6.1M -$5.8M -$3.6M -$1.6M $5.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$6.1M -$5.8M -$3.6M -$1.6M $5.9M
 
Basic EPS (Cont. Ops) -$0.08 -$0.07 -$0.04 -$0.02 $0.06
Diluted EPS (Cont. Ops) -$0.08 -$0.07 -$0.04 -$0.02 $0.06
Weighted Average Basic Share $76.5M $77.8M $84.7M $90M $94.2M
Weighted Average Diluted Share $76.5M $77.8M $84.7M $90M $97.5M
 
EBITDA -$2.8M -$2.4M -$113K $561.8K $8M
EBIT -$3.7M -$3.2M -$791.8K $7K $7.7M
 
Revenue (Reported) $11.4M $8.2M $13M $21.6M $17.9M
Operating Income (Reported) -$3.3M -$3.2M -$861K $904K -$8.4M
Operating Income (Adjusted) -$3.7M -$3.2M -$791.8K $7K $7.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $2.8M $5M $7.5M $6.7M $5.2M
Revenue Growth (YoY) -21.8% 78.5% 49.13% -9.87% -22.38%
 
Cost of Revenues $1.9M $3.2M $5.1M $4.5M $3.6M
Gross Profit $930.5K $1.8M $2.4M $2.3M $1.6M
Gross Profit Margin 33.09% 35.44% 31.81% 33.72% 30.46%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.3M $1.3M $1.3M $2.5M $2.7M
Other Inc / (Exp) -$111.4K -$137.1K -$168.7K -$299.6K $350.4K
Operating Expenses $1.3M $1.3M $1.3M $2.5M $2.7M
Operating Income -$340.9K $437.1K $1.1M -$183.8K -$1.1M
 
Net Interest Expenses $672.4K $507K $317.5K $344.2K $7.4K
EBT. Incl. Unusual Items -$1.1M -$206.7K $569.4K -$827.5K -$764.4K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- -$294.2K
Net Income to Company -$1.1M -$206.7K $569.4K -$827.5K -$470.2K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$1.1M -$206.7K $569.4K -$827.5K -$470.2K
 
Basic EPS (Cont. Ops) -$0.01 -$0.00 $0.01 -$0.01 -$0.00
Diluted EPS (Cont. Ops) -$0.01 -$0.00 $0.01 -$0.01 -$0.00
Weighted Average Basic Share $77.7M $89.3M $89.9M $94.3M $96.1M
Weighted Average Diluted Share $77.7M $89.3M $93.5M $94.3M $96.1M
 
EBITDA -$343.6K $435.1K $1M -$411.4K -$692.3K
EBIT -$452.3K $269.4K $886.9K -$483.3K -$757.1K
 
Revenue (Reported) $2.8M $5M $7.5M $6.7M $5.2M
Operating Income (Reported) -$340.9K $437.1K $1.1M -$183.8K -$1.1M
Operating Income (Adjusted) -$452.3K $269.4K $886.9K -$483.3K -$757.1K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $8.3M $12.7M $18.7M $19.5M $16.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $6.1M $7.5M $12.5M $12.9M $11.1M
Gross Profit $2.2M $5.2M $6.1M $6.6M $5.1M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $4.9M $6.4M $6.1M $8M $18.9M
Other Inc / (Exp) $57.8K -$175.1K -$319.3K -$1M $14.2M
Operating Expenses $4.9M $6.4M $6.1M $8M $18.9M
Operating Income -$2.6M -$1.2M -$22K -$1.3M -$13.8M
 
Net Interest Expenses $2.7M $3M $1.8M $1.3M $492.4K
EBT. Incl. Unusual Items -$5.3M -$4.4M -$2.2M -$3.6M -$66.2K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $14K $13.2K $37.2K $38.1K $179.4K
Net Income to Company -$5.3M -$4.4M -$2.2M -$3.7M -$245.6K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$5.3M -$4.4M -$2.2M -$3.7M -$245.6K
 
Basic EPS (Cont. Ops) -$0.06 -$0.05 -$0.01 -$0.05 -$0.01
Diluted EPS (Cont. Ops) -$0.06 -$0.05 -$0.01 -$0.05 -$0.01
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$1.8M -$792K $302K -$2.1M $785K
EBIT -$2.6M -$1.5M -$310.2K -$2.4M $536K
 
Revenue (Reported) $8.3M $12.7M $18.7M $19.5M $16.2M
Operating Income (Reported) -$2.6M -$1.2M -$22K -$1.3M -$13.8M
Operating Income (Adjusted) -$2.6M -$1.5M -$310.2K -$2.4M $536K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $5.8M $10.3M $16M $13.9M $12.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $4.2M $6.2M $10.8M $9.1M $8.1M
Gross Profit $1.6M $4.1M $5.1M $4.8M $4.1M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.6M $4.1M $4.3M $6.1M $10.9M
Other Inc / (Exp) $146.9K -$87.7K -$476.2K -$613.5K -$2.6M
Operating Expenses $3.6M $4.1M $4.3M $6.1M $10.9M
Operating Income -$2M $38.9K $874.7K -$1.4M -$6.8M
 
Net Interest Expenses $2M $2.3M $1.3M $1M $253.2K
EBT. Incl. Unusual Items -$3.8M -$2.4M -$921.2K -$3M -$9.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $3.2K $14.2K $20.1K -$293.9K
Net Income to Company -$3.8M -$2.4M -$935.5K -$3M -$9.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$3.8M -$2.4M -$935.5K -$3M -$9.2M
 
Basic EPS (Cont. Ops) -$0.04 -$0.03 -$0.00 -$0.04 -$0.10
Diluted EPS (Cont. Ops) -$0.04 -$0.03 -$0.00 -$0.04 -$0.10
Weighted Average Basic Share $233.2M $253.9M $268.4M $282.4M $285M
Weighted Average Diluted Share $233.2M $253.9M $272M $282.4M $285M
 
EBITDA -$1.3M $372.8K $784.5K -$1.8M -$9M
EBIT -$1.9M -$140K $338.3K -$2M -$9.2M
 
Revenue (Reported) $5.8M $10.3M $16M $13.9M $12.2M
Operating Income (Reported) -$2M $38.9K $874.7K -$1.4M -$6.8M
Operating Income (Adjusted) -$1.9M -$140K $338.3K -$2M -$9.2M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $1.5M $591K $1.4M $1.5M $20.9M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.2M $1.1M $1M $2.8M $2.2M
Inventory $513.5K $560.1K $1.1M $991.1K $795.2K
Prepaid Expenses -- -- -- -- --
Other Current Assets $316.2K $95.2K $242K $267.4K $183.6K
Total Current Assets $3.6M $2.4M $3.8M $5.5M $24.2M
 
Property Plant And Equipment $3.2M $2.7M $2.2M $1.9M $1.6M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $2.5M $2.3M $2.1M $1.9M $1.7M
Other Long-Term Assets -- -- -- -- --
Total Assets $9.3M $7.4M $8.1M $9.3M $27.5M
 
Accounts Payable $1.7M $1.6M $2.3M $2.9M $1.6M
Accrued Expenses $583.2K $1.1M $562.4K $67.5K $8.9K
Current Portion Of Long-Term Debt $1M $63.9K $12.1M -- --
Current Portion Of Capital Lease Obligations $383.3K $408K $340.2K $43.3K $11.2K
Other Current Liabilities $167K $167K $167K $167K $167K
Total Current Liabilities $3.9M $3.4M $15.5M $3.2M $2.2M
 
Long-Term Debt $11.2M $14.5M -- $9.9M $11.2M
Capital Leases -- -- -- -- --
Total Liabilities $18.1M $20.6M $18.4M $16.8M $28.3M
 
Common Stock $76.8K $78.1K $89.1K $93.1K $94.4K
Other Common Equity Adj -- -- -- -- --
Common Equity -$8.9M -$13.2M -$10.2M -$7.4M -$782.9K
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$8.9M -$13.2M -$10.2M -$7.4M -$782.9K
 
Total Liabilities and Equity $9.3M $7.4M $8.1M $9.3M $27.5M
Cash and Short Terms $1.5M $591K $1.4M $1.5M $20.9M
Total Debt $12.2M $14.6M $12.1M $9.9M $11.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $318.9K $866K $1.3M $2.5M $4.4M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.5M $3.1M $3.3M $2.5M $1.9M
Inventory $473.6K $709.7K $959.6K $801.6K $886.4K
Prepaid Expenses -- -- -- -- --
Other Current Assets $185.3K $329.5K $562.8K $226.4K $235.6K
Total Current Assets $2.5M $5M $6.1M $6.1M $7.6M
 
Property Plant And Equipment $2.8M $2.3M $1.9M $1.8M $2.5M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $2.4M $2.2M $2M $1.8M $1.6M
Other Long-Term Assets -- -- -- -- --
Total Assets $7.6M $9.5M $10M $9.7M $11.7M
 
Accounts Payable $1.6M $3M $3.1M $4.2M $3.1M
Accrued Expenses $847.3K $694.7K $287.3K $12.8K $572.7K
Current Portion Of Long-Term Debt $30.2K $11.7M $250K -- --
Current Portion Of Capital Lease Obligations $402.9K $387K $78.5K $22.2K $32K
Other Current Liabilities $167K $167K $189.5K $167K $167K
Total Current Liabilities $3.2M $15.9M $3.9M $4.4M $4M
 
Long-Term Debt $14M $255.3K $12.9M $10.9M --
Capital Leases -- -- -- -- --
Total Liabilities $19.8M $19M $20.2M $19.5M $9.7M
 
Common Stock $77.8K $89.3K $89.9K $94.3K $96.2K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$12.2M -$9.5M -$10.2M -$9.9M $1.9M
 
Total Liabilities and Equity $7.6M $9.5M $10M $9.7M $11.7M
Cash and Short Terms $318.9K $866K $1.3M $2.5M $4.4M
Total Debt $14.1M $11.9M $13.2M $10.9M --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$6.1M -$5.8M -$3.6M -$1.6M $5.9M
Depreciation & Amoritzation $894.4K $713.1K $678.8K $554.8K $259.4K
Stock-Based Compensation $1.8M $1.7M $968K $671.7K $520.5K
Change in Accounts Receivable $419.3K $106.8K $101K -$1.8M $544.4K
Change in Inventories -$4.1K -$46.6K -$515.3K $84.3K $196K
Cash From Operations -$1.6M -$1.2M $206K $71K $19.2M
 
Capital Expenditures -- -- $11K $10.7K --
Cash Acquisitions -- -- -- -- --
Cash From Investing $30K $42.5K -$11K -$10.7K --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $2.6M $499.3K $299.4K -- --
Long-Term Debt Repaid -$138.6K -$211K -$70.2K -$2.7K --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $2.5M $288.3K $602.3K $55.7K $209.5K
 
Beginning Cash (CF) $584.9K $1.5M $591K $1.4M $1.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $914.4K -$908.3K $797.3K $115.9K $19.4M
Ending Cash (CF) $1.5M $591K $1.4M $1.5M $20.9M
 
Levered Free Cash Flow -$1.6M -$1.2M $195K $60.3K $19.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$1.1M -$206.7K $569.4K -$827.5K -$470.2K
Depreciation & Amoritzation $108.8K $165.7K $131.4K $71.9K $64.8K
Stock-Based Compensation $369.4K $197.1K $83.1K $69.8K $133.6K
Change in Accounts Receivable -$540.9K -$2M -$335.4K -$505.7K -$290.4K
Change in Inventories -$12.2K -$166K -$111.9K $89.6K $78.6K
Cash From Operations -$212.1K -$807.8K $759.3K $553.7K -$152.2K
 
Capital Expenditures -- -- $10.7K $2.7K $635.8K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -$10.7K -$2.7K -$635.8K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$64.3K -$15.6K -$2.7K -- -$3.3M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- $2.7K -- --
Cash From Financing -$64.3K -$15.6K -- -- -$3.3M
 
Beginning Cash (CF) $595.3K $1.7M $508.6K $1.9M $8.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$276.4K -$823.3K $748.5K $550.9K -$4M
Ending Cash (CF) $318.9K $866K $1.3M $2.5M $4.4M
 
Levered Free Cash Flow -$212.1K -$807.8K $748.5K $550.9K -$787.9K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$5.3M -$4.4M -$2.2M -$3.7M -$245.6K
Depreciation & Amoritzation $747.4K $690.4K $612.2K $304K $249K
Stock-Based Compensation $666.7K $1.5M $1M $528.4K $1.2M
Change in Accounts Receivable -$43.9K -$1.6M -$231.9K $749.4K $474.2K
Change in Inventories $155.9K -$236.2K -$249.9K $158K -$84.8K
Cash From Operations -$1.8M -$7.5K $144.3K $1.2M $15.2M
 
Capital Expenditures -- -- $10.7K $2.7K $699.3K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $1.3M $299.4K -- -- --
Long-Term Debt Repaid -$230.5K -$125.8K -$6.4K -- -$12.6M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $1.1M $521.6K $268.6K $17.8K -$12.6M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$680K $547.1K $391.1K $1.2M $1.9M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$1.8M -$7.5K $133.5K $1.2M $14.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$3.8M -$2.4M -$935.5K -$3M -$9.2M
Depreciation & Amoritzation $535.4K $512.8K $446.2K $195.3K $185K
Stock-Based Compensation $619.2K $453.1K $533.4K $390.1K $1M
Change in Accounts Receivable -$252.1K -$2M -$2.3M $228.6K $158.4K
Change in Inventories $39.9K -$149.6K $115.8K $189.5K -$91.3K
Cash From Operations -$1.5M -$306K -$367.8K $786.1K -$3.3M
 
Capital Expenditures -- -- $10.7K $2.7K $702.1K
Cash Acquisitions -- -- -- -- --
Cash From Investing $9.5K -- -$10.7K -$2.7K -$702K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $499.3K $299.4K $250K -- --
Long-Term Debt Repaid -$151.6K -$66.4K -$2.7K -- -$12.6M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $347.7K $581K $247.3K $209.5K -$12.6M
 
Beginning Cash (CF) $2.6M $4.3M $2.3M $5.9M $40.6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.2M $275K -$131.2K $992.9K -$16.5M
Ending Cash (CF) $1.4M $4.5M $2.1M $6.9M $24M
 
Levered Free Cash Flow -$1.5M -$306K -$378.5K $783.4K -$4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 8.35% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 5.23% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.03% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock